Renal transplant (RT) represents the treatment of choice for end-stage renal disease (ESRD) but harbours a wide range of possible complications and therapeutic challenges of urological competence. Dialysis years and clinical medical background of these patients are risk factors for sexual dysfunction and lower urinary tract symptoms (LUTS). On the contrary, RT itself may have a number of possible surgical complications such as ureteral stenosis and urinary leakage, while immunosuppressive treatment is a known risk factor for de-novo malignancies.
The present review describes the main urologic problems of RT patients and their up-to-date treatment options according to the most recently available literature evidences.
AndrésA.. Cancer incidence after immunosuppressive treatment following kidney transplantation.Crit Rev Oncol Hematol.2005; 56(1): 71–85.
2.
PhyllipsB., BallC., SackettD.. Levels of evidence and grades of recommendation.Oxford Centre for Evidence based Medicine web site http://www.cebm.net/index.aspx?o=1025 Accessed March 15, 2009.
3.
ZagdounE., FicheuxM., LobbedezT.Complicated lymphoceles after kidney transplantation.Transplant Proc.2010; 42(10): 4322–4325.
KaramG., HétetJ.F., MailletF.Late ureteral stenosis following renal transplantation: risk factors and impact on patient and graft survival.Am J Transplant.2006; 6(2): 352–356.
6.
van AalderenM.C., HeutinckK.M., HuismanC., ten BergeI.J.M.. BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response.Netherlands J Med.2012; 70: 172–183.
7.
JuanedaB., AlcarazA., BujonsA.Endourological management is better in early-onset ureteral stenosis in kidney transplantation.Transplant Proc.2005; 37(9): 3825–3827.
8.
AytekinC., BoyvatF., HarmanA., OzyerU., ColakT., HaberalM.. Percutaneous therapy of ureteral obstructions and leak after renal transplantation: long-term results.Cardiovasc Intervent Radiol.2007; 30(6): 1178–1184.
9.
Li MarziV., FilocamoM.T., DattoloE.The treatment of fistulae and ureteral stenosis after kidney transplantation.Transplant Proc.2005; 37(6): 2516–2517.
10.
KimJ.C., BannerM.P., RamchandaniP., GrossmanR.A., PollackH.M.. Balloon dilation of ureteral strictures after renal transplantation.Radiology.1993; 186(3): 717–722.
11.
BacharG.N., MorE., BartalG., AtarE., GoldbergN., BelenkyA.. Percutaneous balloon dilatation for the treatment of early and late ureteral strictures after renal transplantation: long-term follow-up.Cardiovasc Intervent Radiol.2004; 27(4): 335–338.
HeB., BremnerA., HanY.. Classification of ureteral stenosis and associated strategy for treatment after kidney transplant.Exp Clin Transplant.2013; 11(2): 122–127.
14.
KristoB., PhelanM.W., GritschH.A., SchulamP.G.. Treatment of renal transplant ureterovesical anastomotic strictures using antegrade balloon dilation with or without holmium: YAG laser endoureterotomy.Urology.2003; 62(5): 831–834.
15.
GdorY., GabrA.H., FaerberG.J., WolfJ.S.Jr.., Holmium: yttrium-aluminum-garnet laser endoureterotomy for the treatment of transplant kidney ureteral strictures.Transplantation.2008; 85(9): 1318–1321.
16.
ZavosG., PappasP., KaratzasT.Urological complications: analysis and management of 1525 consecutive renal transplantations.Transplant Proc.2008; 40(5): 1386–1390.
17.
KrólR., ZiajaJ., ChudekJ.Surgical treatment of urological complications after kidney transplantation.Transplant Proc.2006; 38(1): 127–130.
18.
TahirW., HakeemA., WhiteA., IrvingH.C., LloydS.N., AhmadN.. Extra-anatomic stent (EAS) as a salvage procedure for transplant ureteric stricture.Am J Transplant.2014; 14(8): 1927–1930.
19.
DavariH.R., YarmohammadiH., MalekhosseiniS.A., SalahiH., BahadorA., SalehipourM.. Urological complications in 980 consecutive patients with renal transplantation.Int J Urol.2006; 13(10): 1271–1275.
20.
StreeterE.H., LittleD.M., CranstonD.W., MorrisP.J.. The urological complications of renal transplantation: a series of 1535 patients.BJU Int.2002; 90(7): 627–634.
CampbellS.C., StreemS.B., ZelchM., HodgeE., NovickA.C.. Percutaneous management of transplant ureteral fistulas: patient selection and long-term results.J Urol.1993; 150(4): 1115–1117.
23.
AlcarazA., BujonsA., PascualX.Percutaneous management of transplant ureteral fistulae is feasible in selected cases.Transplant Proc.2005; 37(5): 2111–2114.
24.
MazzucchiE., SouzaG.L., HisanoM.Primary reconstruction is a good option in the treatment of urinary fistula after kidney transplantation.Int Braz J Urol.2006; 32(4): 398–403, discussion 403–404.
25.
DinckanA., TekinA., TurkyilmazS.Early and late urological complications corrected surgically following renal transplantation.Transpl Int.2007; 20(8): 702–707.
26.
BastonC., HarzaM., PredaA.Comparative urologic complications of ureteroneocystostomy in kidney transplantation: transvesical Leadbetter-Politano versus extravesical Lich-Gregoir technique.Transplant Proc.2014; 46(1): 176–179.
27.
AmeerA., AljiffryM., JamalM.Complications of ureterovesical anastomosis in adult renal transplantation: comparison of the Lich-Gregoire and the Taguchi techniques.Ann Transplant.2011; 16(3): 82–87.
28.
PikeT.W., PandanaboyanaS., Hope-JohnsonT., HostertL., AhmadN.. Ureteric reconstruction for the management of transplant ureteric stricture: a decade of experience from a single centre.Transpl Int.2015; 28(5): 529–534.
29.
SalomonL., SaportaF., AmsellemD.Results of pyeloureterostomy after ureterovesical anastomosis complications in renal transplantation.Urology.1999; 53(5): 908–912.
30.
SchultM., KüsterJ., KliemV.Native pyeloureterostomy after kidney transplantation: experience in 48 cases.Transpl Int.2000; 13(5): 340–343.
31.
Mahdavi ZafarghandiR., SheikhiZh.Extensive ureteral stricture in renal transplant recipients: prevalence and impact on graft and patient survival.Int J Organ Transplant Med.2013; 4(4): 165–171.
32.
MazzucchiE., NahasW.C., AntonopoulosI.M., PiovesanA.C., lanhezL.E., ArapS.. Surgical complications of graft nephrectomy in the modern transplant era.J Urol.2003; 170(3): 734–737.
33.
JohnstonO., RoseC., LandsbergD., GourlayW.A., GillJ.S.. Nephrectomy after transplant failure: current practice and outcomes.Am J Transplant.2007; 7(8): 1961–1967.
34.
TournaN.J., SenerA., CaumartinY., WarrenJ., NguanC.Y., LukeP.P.. Extracapsular versus intracapsular allograft nephrectomy: impact on allosensitization and surgical outcomes.Can Urol Assoc J.2011; 5(1): 49–52.
35.
StewartJ.H., VajdicC.M., van LeeuwenM.T.The pattern of excess cancer in dialysis and transplantation.Nephrol Dial Transplant.2009; 24(10): 3225–3231.
36.
BrunnerF.P., LandaisP., SelwoodNH; European Dialysis and Transplantation Association-European Renal Association. Malignancies after renal transplantation: the EDTA-ERA registry experience.Nephrol Dial Transplant.1995; 10(suppl 1): 74–80.
37.
MahonyJ.F., CatersonR.J., CoulshedS., StewartJ.H., SheilA.G.. Twenty and 25 years survival after cadaveric renal transplantation.Transplant Proc.1995; 27(3): 2154–2155.
38.
SheilA.G.. Patterns of malignancies following renal transplantation.Transplant Proc.1999; 31(1-2): 1263–1265.
39.
BijolV., MendezG.P., HurwitzS., RennkeH.G., NoséV.. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.Am J Surg Pathol.2006; 30(5): 575–584.
40.
MelchiorS., FranzaringL., ShardanA.Urological de novo malignancy after kidney transplantation: a case for the urologist.J Urol.2011; 185(2): 428–432.
41.
BredaA., LuccarelliG., Rodriguez-FabaO., GuiradoL., FacundoC., BettocchiC.Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long term comparative retrospective study with RCC diagnosed in general population.World J Urol.2015; 33: 1–7.
42.
PennI.. Occurrence of cancers in immunosuppressed organ transplant recipients.Clin Transpl.1998; 0890–9016: 147–158.
43.
AielloF.B.. Incidental carcinoma of native kidneys in dialyzed and renal transplant patients: do we need new guidelines?Transpl Int.2015; 28(7): 790–792.
44.
YanL., ChenP., ChenE.Z., GuA., JiangZ.Y.. Risk of bladder cancer in renal transplant recipients: a meta-analysis.Br J Cancer.2014; 110(7): 1871–1877.
45.
ZhangB., ShenC., HanW.K., YuW.. Comparison of clinicopathologic characteristics of urothelial carcinoma between patients after renal transplantation and on dialysis.Transplantation.2014; 98(5): 552–556.
46.
PrabharasuthD., MosesK.A., BernsteinM., DalbagniG., HerrH.W.. Management of bladder cancer after renal transplantation.Urology.2013; 81(4): 813–819.
47.
WuM.J., LianJ.D., YangC.R., ChengC.H., ChenC.H., LeeW.C.High cumulative incidence of Urinary tract transitional cell carcinoma after kidney transplantation in Taiwan;
48.
KasiskeB.L., SnyderJ.J., GilbertsonD.T.Cancer after kidney transplantation in the United States.Am J Transplant.2004; 4: 905–913.
49.
KleinclaussF.M., NeuzilletY., TillouX.Renal Transplantation Committee of French Urological Association. Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipients: multicenter study from Renal Transplantation Committee of French Urological Association.Urology.2008; 72(6): 1366–1370.
50.
KinahanT.J., Mc LoughlinM.G., MansonA.D.. Radical prostatectomy for localized prostatic carcinoma in the renal transplant patient.J Urol.1991; 146(1): 104–107.
51.
KaramG., GiessingM.. Bladder dysfunction following renal transplantation is it predictable?Transplant Proc.2011; 43(1): 387–390.
52.
ChunJ.M., JungG.O., ParkJ.B.Renal transplantation in patients with a small bladder.Transplant Proc.2008; 40(7): 2333–2335.
53.
MartinX., AboutaiebR., SolimanS., el EssawyA., DawahraM., LefrancoisN.. The use of long-term defunctionalized bladder in renal transplantation: is it safe?Eur Urol.1999; 36(5): 450–453.
54.
SerranoD.P., FlechnerS.M., ModlinC.S., WynerL.M., NovickA.C.. Transplantation into the long-term defunctionalized bladder.J Urol.1996; 156(3): 885–888.
55.
ZermannD.H., JanitzkyA., HöhneM., SchubertJ.. Frequency and nocturia after successful renal transplantation: a normal situation?BJU Int.2006; 97(3): 555–558.
56.
BlancoM., MedinaJ., PamplonaM., MirandaN., GonzalezE., AguirreJ.F.Outcome of renal transplantation in adult patients with augmented bladders.Transp Proc.2009; 41(6): 2382–2384.
57.
Ferreira CassiniM., ColognaA.J., Ferreira AndradeM.Lithiasis in 1,313 kidney transplants: incidence, diagnosis, and management.Transplant Proc.2012; 44(8): 2373–2375.
58.
CicerelloE., MerloF., ManganoM., CovaG., MaccatrozzoL.. Urolithiasis in renal transplantation: diagnosis and management.Arch Ital Urol Androl.2014; 86(4): 257–260.
59.
MamarelisG., VernadakisS., MorisD.Lithiasis of the renal allograft, a rare urological complication following renal transplantation: a single-center experience of 2,045 renal transplantations.Transplant Proc.2014; 46(9): 3203–3205.
60.
OlsburghJ., ThomasK., WongK.Incidental renal stones in potential live kidney donors: prevalence, assessment and donation including the role of ex vivo ureteroscopy.BJU Int.2012.
61.
SchadeG.R., WolfJ.S.Jr., FaerberG.J.. Ex-vivo ureteroscopy at the time of live donor nephrectomy.J Endourol.2011; 25(9): 1405–1409.
62.
RashidM.G., KonnakJ.W., WolfJ.S.Jr.. Ex vivo ureteroscopic treatment of calculi in donor kidneys at renal transplantation.J Urol.2004; 171(1): 58–60.
63.
WongK.A., OlsburghJ.. Management of stones in renal transplant.Curr Opin Urol.2013; 23(2): 175–179.
64.
KlinglerH.C., KramerG., LoddeM., MarbergerM.. Urolithiasis in allograft kidneys.Urology.2002; 59(3): 344–348.
65.
VerrierC., BessedeT., HajjP., AoubidL., EschwegeP., BenoitG.. Decrease in and management of urolithiasis after kidney transplantation.J Urol.2012; 187(5): 1651–1655.
66.
ChallacombeB., DasguptaP., TiptaftR.Multimodal management of urolithiasis in renal transplantation.BJU Int.2005; 96(3): 385–389.
67.
LiS.D., WangQ.T., ChenW.G.. Treatment of urinary lithiasis following kidney transplantation with extracorporeal shock-wave lithotripsy.Chin Med J (Engl).2011; 124(9): 1431–1434.
68.
HyamsE., MarienT., BruhnA.Ureteroscopy for transplant lithiasis.J Endourol.2012; 26(7): 819–822.
69.
BasiriA., NikoobakhtM.R., SimforooshN., Hosseini MoghaddamS.M.. Ureteroscopic management of urological complications after renal transplantation.Scand J Urol Nephrol.2006; 40(1): 53–56.
70.
KrambeckA.E., LeroyA.J., PattersonD.E., GettmanM.T.. Percutaneous nephrolithotomy success in the transplant kidney.J Urol.2008; 180(6): 2545–2549.
71.
HeZ., LiX., ChenL., ZengG., YuanJ.. Minimally invasive percutaneous nephrolithotomy for upper urinary tract calculi in transplanted kidneys.BJU Int.2007; 99(6): 1467–1471.
72.
DiemontW.L., VrugginkP.A., MeulemanE.J., DoesburgW.H., LemmensW.A., BerdenJ.H.. Sexual dysfunction after renal replacement therapy.Am J Kidney Dis.2000; 35(5): 845–851.
73.
RosasS.E., JoffeM., FranklinE.Association of decreased quality of life and erectile dysfunction in hemodialysis patients.Kidney Int.2003; 64(1): 232–238.
74.
HoldsworthS.R., de KretserD.M., AtkinsR.C.. A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function.Clin Nephrol.1978; 10(4): 146–150.
75.
HricikD.E., HalbertR.J., BarrM.L.Life satisfaction in renal transplant recipients: preliminary results from the transplant learning center.Am J Kidney Dis.2001; 38(3): 580–587.
76.
MatasA.J., HalbertR.J., BarrM.L.Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis.Clin Transplant.2002; 16(2): 113–121.
77.
MelmanA., GingelJ.C.. The epidemiology and pathophysiology of erectile dysfunction.J Urol.1999; 161: 5e11.
78.
TooriansA.W., JanssenE., LaanE.Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response.Nephrol Dial Transplant.1997; 12: 2654e2663.
79.
HegartyP.K., OlsburghJ.. Renal replacement and male sexuality.Transplant Proc.2012; 44(6): 1804–1805.
80.
MehrsaiA., MousaviS., NikoobakhtM., KhanlarpoorT., ShekarpourL., PourmandG.. Improvement of erectile dysfunction after kidney transplantation: the role of the associated factors.Urol J.2006; 3(4): 240–244.
81.
TavallaiiS.A., MirzamaniM., Heshmatzade BehzadiA.Sexual function: a comparison between male renal transplant recipients and hemodialysis patients.J Sex Med.2009; 6(1): 142–148.
82.
NassirA., MotavalliS.M., AghdamB.. Sexual function in male patients undergoing treatment for renal failure: a prospective view.J Sex Med.2009; 6(12): 3407–3414.
83.
MalavaudB., RostaingL., RischmannP., SarramonJ.P., DurandD.. High prevalence of erectile dysfunction after renal transplantation.Transplantation.2000; 69(10): 2121–2124.
84.
MiraneV., LongoN., FuscoF.Renal transplantation does not improve erectile function in hemodialysed patients.Eur Urol.2009; 56(6): 1047–1053.
85.
EspinozaR., GracidaC., CancinoJ., IbarraA.. Prevalence of erectile dysfunction in kidney transplant recipients.Transplant Proc.2006; 38(3): 916–917.
86.
El-BahnasawyM.S., El-AssmyA., DawoodA.Effect of the use of internal iliac artery for renal transplantation on penile vascularity and erectile function: a prospective study.J Urol.2004; 172(6 Pt 1): 2335–2339.
87.
GonteroP., OderdaM., FilippiniC.Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries?Asian J Andrai.2012; 14(4): 621–625.
88.
LasaponaraF., SedighO., PasqualeG.Phosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantation.J Sex Med.2013; 10(11): 2798–2814.
89.
HatzimouratidisK., AmarE., EardleyI.European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.Eur Urol.2010; 57(5): 804–814.
90.
CuellarD.C., SklarG.N.. Penile prosthesis in the organ transplant recipient.Urology.2001; 57(1): 138–141.
91.
StemberD.S., GarberB.B., PeritoP.E.. Outcomes of abdominal wall reservoir placement in inflatable penile prosthesis implantation: a safe and efficacious alternative to the space of Retzius.J Sex Med.2014; 11(2): 605–612.
92.
TooriansA.W., JanssenE., LaanE.Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response.Nephrol Dial Transplant.1997; 12(12): 2654–2663.
93.
HoldsworthS., AtkinsR., de KretserD.. The pituitary-testicular axis in men with chronic renal failure.N Engl J Med.1977; 296: 1245–1249.
94.
DeCelisR., Pedrón-NuevoN.. Male fertility of kidney transplant patients with one to ten years of evolution using a conventional immunosuppressive regimen.Arch Androl.1999; 42(1): 9–20.
95.
Lessan-PezeshkiM., GhazizadehS.. Sexual and reproductive function in end-stage renal disease and effect of kidney transplantation.Asian J Androl.2008; 10(3): 441–446.
96.
SeethalakshmiL., DiamondD.A., MalhotraR.K., MazanitisS.G., KumarS., MenonM.. Cyclosporine-induced testicular dysfunction: a separation of the nephrotoxic component and an assessment of a 60-day recovery period.Transplant Proc.1988; 20(3) (Suppl 3): 1005–1010.
97.
SeethalakshmiL., FloresC., CarboniA.A., BalaR., DiamondD.A., MenonM.. Cyclosporine: its effects on testicular function and fertility in the prepubertal rat.J Androl.1990; 11(1): 17–24.
98.
SkrzypekJ., KrauseW.. Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment.Andrologia.2007; 39(5): 198–199.
99.
BalmoriC., GuillénA., MontansJ., BronetF., García-VelascoJ.A.. Successful ICSI in an azoospermic and kidney transplant man with type 1 primary hyperoxaluria and first histopathological testicular findings described in the literature.Andrologia.2015; 47(1): 109–111.
